Science

Brightening Life: Simple Formaldehyde Synthesis of Fluorescent Molecules

By Xavier Roxy

September 30, 2024

389

A groundbreaking development in the synthesis of organic fluorophores has been achieved by a team of researchers, who have managed to produce these molecules more cost-effectively and atom-efficiently than ever before. This innovative process involves formaldehyde, the simplest carbon molecule. The findings were published in Angewandte Chemie International Edition on September 18. 
 
Organic fluorophores are substances known for their ability to fluoresce—they absorb specific wavelengths of light and then re-emit it. These properties make them invaluable tools in medical diagnostics and bioimaging applications such as tracking cancer cells or conducting genetic analysis. However, one commonly used type of organic fluorophore, trimethine cyanine (Cy3), traditionally requires a complex compound with high molecular weight for its synthesis. This leads to numerous byproducts and low atom efficiency. 
 
The research team sought an alternative approach using formaldehyde (HCHO), a simple molecule consisting only of one carbon (C) atom, two hydrogen (H) atoms, and one oxygen (O) atom. While potentially toxic due to its ability to react with proteins and DNA in vivo, formaldehyde is also highly useful in creating new carbon-carbon bonds during organic synthesis. 
 
By using this simple compound instead of traditional complex ones as a source for additional carbon required during the Cy3 synthesis process, the team was able to significantly reduce the size of molecules involved while maximizing atomic efficiency at the same time. They even simplified what was once considered a multi-step asymmetric Cy3 production into a single-pot reaction that does away with unnecessary stages thereby increasing synthetic efficiency. 
 
Furthermore, the researchers investigated if their novel technique could be extended from laboratory settings into actual cells and tissues, given that certain amounts of formaldehyde naturally occur within living organisms as part of metabolic processes. Using rat small intestine tissue samples under inflammation-induced conditions versus normal conditions showed interesting results: those under inflammation exhibited weaker fluorescence signals compared to normal samples due to lower formaldehyde levels, thus limiting Cy3 synthesis. This exciting discovery shows that the newly developed method is applicable not only for in vitro but also for in vivo environments. 
 
The research team was spearheaded by Professor Young-Tae Chang from the Department of Chemistry at POSTECH and Dr. Sun Hyeok Lee from POSTECH's Basic Science Research Institute. 
 
"This marks the first successful synthesis of Cy3 molecules using formaldehyde," stated Professor Chang. "Our method is not only cost-effective and highly atom-efficient, but it can also be utilized in vivo, expanding the potential applications of organic fluorophores in life sciences research and diagnostics." 
 
This breakthrough stands as testament to how simple molecules like formaldehyde can revolutionize complex processes such as organic fluorophore synthesis, thereby potentially enhancing our understanding and diagnosis of various diseases, including cancer.


LATEST ARTICLES IN Science

Electric Field Revealed: A New Force in Earth's Atmosphere.

Unveiling the Most Detailed Infrared Milky Way Map Yet.

Upbeat Hong Kong Exporters Anticipate Sales Growth.

New Species of Ghost Shark Discovered Near Australia and New Zealand.

Join Our Newsletter

Advertisement

Popular Articles

  • Mar 13, 2024

    Anyone But You - A Romantic Comedy Surprise of 2023
  • Feb 01, 2024

    AI Company About to Revolutionize the Medical Space?
  • Jul 31, 2024

    Apple Anticipates Higher Revenue in Thursday's Earnings Report
  • Aug 01, 2024

    Samsung Galaxy S25: Potential Big Screen and Camera Upgrades

Categories

AI Blockchain Business Health Markets
Politics Real Estate Tech US News World News
Sports Entertainment Science Editorial Commodities

Useful Links

Home About Pricing Legal
Advertise Terms & Conditions Privacy Policy Contact

Subscribe

© Financial News is owned and operated by FN Publishing Ltd. No portion of this site can be reproduced without explicit written permission of FN Publishing Ltd.

By accessing this website, you are agreeing to be bound by our terms and conditions. Please read carefully before using.